182
Participants
Start Date
January 5, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
Fosrenol (Lanthanum Carbonate)
The starting dose is a total daily dose of 2250mg of Fosrenol (Lanthanum carbonate) to a maximum dose of 3000mg daily. Chewable tablets will be administered orally with meals in 750mg and 1000mg strength tablets.
Sevelamer hydrochloride
The starting dose is a total daily dose of 4800mg of sevelamer hydrochloride up to a maximum of 6400 mg daily. Sevelamer hydrochloride 800mg tablets, administered orally with meals.
KfH Nierenzentrum, Berlin
Winthrop Dialysis Center, Mineola
SUNY at Stony Brook NY, Stony Brook
KfH Dialysezentrum/Berlin, Berlin
Clinical Research & Consulting Center, LLC, Fairfax
Dialysezentrum Barmbeck, Hamburg
Alexandria Kidney, Alexandria
Wake Nephrology Associates, Raleigh
Southeastern Nephrology Associates, Wilmington
Carolina Nephrology, PA, Greenville
Kidney Care Associates, LLC, Augusta
Renal Physicians of Georgia, Macon
Shands University of Florida Outpatient Dialysis, Gainesville
Pines Clinical Research, Pembroke Pines
Discovery Medical Research Group, Ocala
Georg-August-Universitat Universitatsmedizin Abt. Nephrologie u. Rheumatologie, Göttingen
VA Tennessee Valley Healthcare System, Nashville
Nephrology Inc., Mishawaka
KfH Nierenzentrum/Dulmen, Dülmen
Evanston Northwestern Hospital, Evanston
Research by Design, LLC, Evergreen Park
KfH Nierenzentrum/Bad/Konig, Bad König
Creighton University Medical Center, Omaha
Renal Associates of Baton Rouge, Baton Rouge
Clinical Research Connections, Jonesboro
Rosa Verde Tower, San Antonio
University of Texas Health Science Center at San Antonio Medicine/Nephrology, San Antonio
Western Nephrology & Metabolic Bone Disease, PC, Thornton
KfH-Dialysezentrum/Rosenheim, Rosenheim
AKDHC Medical Research Services, LLC, Phoenix
DSI Renal Inc., Mesa
Southwest Kidney Institute, PLC, Tempe
Tempe
University of Arizona Health Service Center, Tucson
VA Greater Los Angeles Health Care System, West LA, Los Angeles
South Valley Dialysis Center, Encino
Apex Research of Riverside, Riverside
North Valley Nephrology, Yuba City
Northwest Renal Clinic, Portland
Clinical Research Center of Indian River Medical Center, Vero Beach
Hypertension and Nephrology, Associates, Eatontown
KfH-Nierenzentrum/Jena, Jena
Jose Cangiano, MD, San Juan
Churchill Hospital Oxford Kidney Unit, Oxford
Lead Sponsor
Shire
INDUSTRY